SEZARY SYNDROME
Clinical trials for SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare skin cancer
Disease control Recruiting nowThis study tests whether combining a light-based blood treatment (ECP) with a targeted antibody drug (mogamulizumab) can better control erythrodermic cutaneous T-cell lymphoma (CTCL), a rare skin cancer. About 34 adults with advanced CTCL will receive both treatments to see if th…
Matched conditions: SEZARY SYNDROME
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
New drug watch: mogamulizumab under Real-World scrutiny for rare skin cancers
Disease control Recruiting nowThis study tracks 15 adults with mycosis fungoides or Sezary syndrome who receive mogamulizumab, a targeted antibody therapy, in everyday medical practice. Researchers will record side effects and measure how well the drug controls the cancer using a standard scoring system. The …
Matched conditions: SEZARY SYNDROME
Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
Can a light therapy shrink blood cancer cells? new trial aims to find out
Disease control Recruiting nowThis study tests a treatment called extracorporeal photopheresis (ECP) in 20 people with Sezary Syndrome, a rare blood cancer that affects the skin. ECP involves taking blood, treating it with light and a drug, then returning it to the body. The goal is to see if ECP can reduce c…
Matched conditions: SEZARY SYNDROME
Sponsor: Oleg E. Akilov, MD, PhD • Aim: Disease control
Last updated May 17, 2026 02:40 UTC
-
Could a lower dose of this cancer drug be just as effective?
Disease control Recruiting nowThis study tests a lower dose of the drug brentuximab vedotin in people with mycosis fungoides, Sezary syndrome, or lymphomatoid papulosis—types of lymphoma that affect the skin. The goal is to see if the lower dose can still control the disease while causing fewer side effects. …
Matched conditions: SEZARY SYNDROME
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Skin disease samples wanted for research
Knowledge-focused Recruiting nowThis study collects blood, urine, and skin samples from 200 adults with cutaneous T-cell lymphoma, eczema, or atopic dermatitis. The samples are stored and used for current and future research to better understand these skin conditions. Participants must be 18 or older and have a…
Matched conditions: SEZARY SYNDROME
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC